BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7490131)

  • 1. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.
    Schirmbeck R; Böhm W; Reimann J
    Eur J Immunol; 1994 Sep; 24(9):2068-72. PubMed ID: 8088327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation.
    Schirmbeck R; Böhm W; Melber K; Reimann J
    J Immunol; 1995 Nov; 155(10):4676-84. PubMed ID: 7594467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
    Harding CV; Song R
    J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y; Li Y; Kapp JA
    Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
    Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
    J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation.
    Garcia MR; Graham S; Harris RA; Beverley SM; Kaye PM
    Eur J Immunol; 1997 Apr; 27(4):1005-13. PubMed ID: 9130657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
    Michalek MT; Grant EP; Rock KL
    J Immunol; 1996 Jul; 157(2):617-24. PubMed ID: 8752909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation.
    Schirmbeck R; Melber K; Reimann J
    Eur J Immunol; 1995 Apr; 25(4):1063-70. PubMed ID: 7537671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
    Chen L; Jondal M
    Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
    Ke Y; McGraw CL; Hunter RL; Kapp JA
    Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
    Schirmbeck R; Zerrahn J; Kuhröber A; Deppert W; Reimann J
    Eur J Immunol; 1993 Jul; 23(7):1528-34. PubMed ID: 8325328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.